Insulet
PODD
$340.31
Share price
5.23%
Change (1 day)
49.55%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Revenue for Insulet (PODD)
Revenue in 2024 (TTM): S$2.76 Billion
According to Insulet's latest financial reports the company's current revenue (TTM 
) is S$2.71 Billion. an increase over the revenue in the year 2023 that were of S$2.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Insulet from 2006 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$2.81 B | 25.63% |
| 2023 | S$2.24 B | 28.09% |
| 2022 | S$1.74 B | 17.8% |
| 2021 | S$1.48 B | 24.16% |
| 2020 | S$1.19 B | 20.22% |
| 2019 | S$0.99 B | 29.2% |
| 2018 | S$0.77 B | 24.18% |
| 2017 | S$0.62 B | 16.78% |
| 2016 | S$0.53 B | 34% |
| 2015 | S$0.39 B | 3.9% |
| 2014 | S$0.38 B | 21.86% |
| 2013 | S$0.31 B | 21.11% |
| 2012 | S$0.25 B | 31.09% |
| 2011 | S$0.19 B | 57.86% |
| 2010 | S$0.12 B | 34.74% |
| 2009 | S$92.7 M | 79.77% |
| 2008 | S$51.56 M | 167.99% |
| 2007 | S$19.24 M | 221.02% |
| 2006 | S$5.99 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | S$3.12 B | 14.99% | 🇺🇸 USA |
 | S$1.20 B | -55.83% | 🇺🇸 USA |
 | S$5.29 B | 94.68% | 🇺🇸 USA |
 | S$116.53 B | 4,187.56% | 🇺🇸 USA |
 | S$55.03 B | 1,925.00% | 🇺🇸 USA |
 | S$43.55 B | 1,502.58% | 🇮🇪 Ireland |
 | S$59.09 B | 2,074.30% | 🇺🇸 USA |